Premium
Commentary on ‘Opioid agonist treatment and patient outcomes during the COVID ‐19 pandemic in south east Sydney, Australia’
Author(s) -
Steele Maureen,
Acheson Liam S.
Publication year - 2022
Publication title -
drug and alcohol review
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.018
H-Index - 74
eISSN - 1465-3362
pISSN - 0959-5236
DOI - 10.1111/dar.13439
Subject(s) - pharmacy , buprenorphine , medicine , methadone , opioid use disorder , pandemic , adverse effect , family medicine , dosing , service delivery framework , service (business) , public health , covid-19 , medical emergency , nursing , opioid , psychiatry , business , pharmacology , marketing , receptor , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom